Literature DB >> 24225281

Lipopolysaccharide binding protein in cirrhotic patients with severe sepsis.

Yi-Yuan Chen1, Jau-Min Lien1, Yun-Shing Peng2, Yung-Chang Chen3, Ya-Chung Tian3, Ji-Tseng Fang3, Hsing-Chih Huang1, Pang-Chi Chen1, Chih-Wei Yang3, Cheng-Shyong Wu4, Ming-Hung Tsai5.   

Abstract

BACKGROUND: Lipopolysaccharide binding protein (LBP) is an acute-phase protein produced by the liver. It has been shown that LBP plays an important role in the inflammatory response to sepsis. LBP has also been shown to protect animals from endotoxin challenge by facilitating the removal of endotoxin from the blood circulation. Cirrhotic patients are susceptible to bacterial infection. It is unknown whether pre-existing liver dysfunction impacts the LBP levels and thus the prognosis in severe sepsis.
METHODS: We evaluated the serum LBP, inflammatory cytokines, and the relationship between LBP concentrations, functional liver reserve and outcomes in 58 critically ill cirrhotic patients with severe sepsis.
RESULTS: The serum LBP levels were significantly higher in 28-day survivors, while the interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels were significantly higher in non-survivors. We analyzed the receiver operating characteristic (ROC) curve to determine the cut-off point for LBP to predict 28-day mortality. The cumulative rates at 28 days were 58.3% versus 16.7% for the high LBP group (>46 ng/mL) and low LBP group (<46 ng/mL) (p < 0.001). The high-LBP group had significantly lower INR, Child-Pugh, Model for End-stage Liver Disease (MELD) scores and TNF-α level. Meanwhile, the LBP levels were inversely correlated with INR, and Child-Pugh, MELD and sequential organ failure assessment (SOFA) scores.
CONCLUSION: The concentration of LBP is associated inversely with disease severity scores and outcomes in critically ill cirrhotic patients with severe sepsis.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  lipopolysaccharide binding protein; liver cirrhosis; severe sepsis

Mesh:

Substances:

Year:  2013        PMID: 24225281     DOI: 10.1016/j.jcma.2013.10.006

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  5 in total

1.  Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants in Patients with Spontaneous Bacterial Peritonitis.

Authors:  Murat M M Harputluoglu; Ramazan Dertli; Baris Otlu; Ulvi Demirel; Ozkan Yener; Yilmaz Bilgic; Mehmet Ali Erdogan; Yahya Atayan; Yasir Furkan Cagin
Journal:  Dig Dis Sci       Date:  2016-01-02       Impact factor: 3.199

2.  TLR4/CD14 Variants-Related Serologic and Immunologic Dys-Regulations Predict Severe Sepsis in Febrile De-Compensated Cirrhotic Patients.

Authors:  Wen-Chien Fan; Chih-Wei Liu; Shuo-Ming Ou; Chia-Chang Huang; Tzu-Hao Li; Kuei-Chuan Lee; Shiang-Fen Huang; Ying-Ying Yang; Yun-Cheng Hsieh; Shie-Liang Hsieh; Ming-Chih Hou; Han-Chieh Lin
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

Review 3.  The Role of Lipopolysaccharide-Induced Cell Signalling in Chronic Inflammation.

Authors:  Martin J Page; Douglas B Kell; Etheresia Pretorius
Journal:  Chronic Stress (Thousand Oaks)       Date:  2022-02-08

4.  Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children.

Authors:  Anika Nier; Anna Janina Engstler; Ina Barbara Maier; Ina Bergheim
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

Review 5.  Fluid Biomarkers for Predicting the Prognosis of Liver Cirrhosis.

Authors:  Si-Hai Chen; Qin-Si Wan; Ting Wang; Kun-He Zhang
Journal:  Biomed Res Int       Date:  2020-03-20       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.